Global Biosimilars Market Report 2019, Competitive Landscape, Trends and Opportunities
The Biosimilars market has witnessed growth from USD XX million to USD XX million from 2014 to 2019. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2026.
The report mainly studies the size, recent trends and development status of the Biosimilars market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Biosimilars market.
Major players in the global Biosimilars market include:
Dr. Reddy’s Laboratories Ltd.
Samsung Bioepis
Mylan N.V
F. Hoffmann-La Roche AG
Sandoz International GmbH
Teva Pharmaceutical Industries Ltd.
Biocon
Pfizer Inc.
Amgen Inc
On the basis of types, the Biosimilars market is primarily split into:
Human growth hormone
Erythropoietin
Monoclonal antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Others
On the basis of applications, the market covers:
Oncology
Blood Disorders
Growth Hormonal Deficiency
Chronic and Autoimmune Disorders
Others
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Central and South America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions
Chapter 1 provides an overview of Biosimilars market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Biosimilars market by type, application, and region are also presented in this chapter.
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 provides a full-scale analysis of major players in Biosimilars industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 4 gives a worldwide view of Biosimilars market. It includes production, market share revenue, price, and the growth rate by type.
Chapter 5 focuses on the application of Biosimilars, by analyzing the consumption and its growth rate of each application.
Chapter 6 is about production, consumption, export, and import of Biosimilars in each region.
Chapter 7 pays attention to the production, revenue, price and gross margin of Biosimilars in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 9 introduces the industrial chain of Biosimilars. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.
Chapter 10 provides clear insights into market dynamics.
Chapter 11 prospects the whole Biosimilars market, including the global production and revenue forecast, regional forecast. It also foresees the Biosimilars market by type and application.
Chapter 12 concludes the research findings and refines all the highlights of the study.
Chapter 13 introduces the research methodology and sources of research data for your understanding.
Years considered for this report:
The report mainly studies the size, recent trends and development status of the Biosimilars market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Biosimilars market.
Major players in the global Biosimilars market include:
Dr. Reddy’s Laboratories Ltd.
Samsung Bioepis
Mylan N.V
F. Hoffmann-La Roche AG
Sandoz International GmbH
Teva Pharmaceutical Industries Ltd.
Biocon
Pfizer Inc.
Amgen Inc
On the basis of types, the Biosimilars market is primarily split into:
Human growth hormone
Erythropoietin
Monoclonal antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Others
On the basis of applications, the market covers:
Oncology
Blood Disorders
Growth Hormonal Deficiency
Chronic and Autoimmune Disorders
Others
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Central and South America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions
Chapter 1 provides an overview of Biosimilars market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Biosimilars market by type, application, and region are also presented in this chapter.
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 provides a full-scale analysis of major players in Biosimilars industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 4 gives a worldwide view of Biosimilars market. It includes production, market share revenue, price, and the growth rate by type.
Chapter 5 focuses on the application of Biosimilars, by analyzing the consumption and its growth rate of each application.
Chapter 6 is about production, consumption, export, and import of Biosimilars in each region.
Chapter 7 pays attention to the production, revenue, price and gross margin of Biosimilars in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 9 introduces the industrial chain of Biosimilars. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.
Chapter 10 provides clear insights into market dynamics.
Chapter 11 prospects the whole Biosimilars market, including the global production and revenue forecast, regional forecast. It also foresees the Biosimilars market by type and application.
Chapter 12 concludes the research findings and refines all the highlights of the study.
Chapter 13 introduces the research methodology and sources of research data for your understanding.
Years considered for this report:
- Historical Years: 2014-2018
- Base Year: 2019
- Estimated Year: 2019
- Forecast Period: 2019-2026
1 BIOSIMILARS MARKET OVERVIEW
1.1 Product Overview and Scope of Biosimilars
1.2 Biosimilars Segment by Type
1.2.1 Global Biosimilars Production and CAGR (%) Comparison by Type (2014-2026)
1.2.2 The Market Profile of Human growth hormone
1.2.3 The Market Profile of Erythropoietin
1.2.4 The Market Profile of Monoclonal antibodies
1.2.5 The Market Profile of Insulin
1.2.6 The Market Profile of Interferon
1.2.7 The Market Profile of Granulocyte-Colony Stimulating Factor
1.2.8 The Market Profile of Others
1.3 Global Biosimilars Segment by Application
1.3.1 Biosimilars Consumption (Sales) Comparison by Application (2014-2026)
1.3.2 The Market Profile of Oncology
1.3.3 The Market Profile of Blood Disorders
1.3.4 The Market Profile of Growth Hormonal Deficiency
1.3.5 The Market Profile of Chronic and Autoimmune Disorders
1.3.6 The Market Profile of Others
1.4 Global Biosimilars Market by Region (2014-2026)
1.4.1 Global Biosimilars Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)
1.4.2 United States Biosimilars Market Status and Prospect (2014-2026)
1.4.3 Europe Biosimilars Market Status and Prospect (2014-2026)
1.4.3.1 Germany Biosimilars Market Status and Prospect (2014-2026)
1.4.3.2 UK Biosimilars Market Status and Prospect (2014-2026)
1.4.3.3 France Biosimilars Market Status and Prospect (2014-2026)
1.4.3.4 Italy Biosimilars Market Status and Prospect (2014-2026)
1.4.3.5 Spain Biosimilars Market Status and Prospect (2014-2026)
1.4.3.6 Russia Biosimilars Market Status and Prospect (2014-2026)
1.4.3.7 Poland Biosimilars Market Status and Prospect (2014-2026)
1.4.4 China Biosimilars Market Status and Prospect (2014-2026)
1.4.5 Japan Biosimilars Market Status and Prospect (2014-2026)
1.4.6 India Biosimilars Market Status and Prospect (2014-2026)
1.4.7 Southeast Asia Biosimilars Market Status and Prospect (2014-2026)
1.4.7.1 Malaysia Biosimilars Market Status and Prospect (2014-2026)
1.4.7.2 Singapore Biosimilars Market Status and Prospect (2014-2026)
1.4.7.3 Philippines Biosimilars Market Status and Prospect (2014-2026)
1.4.7.4 Indonesia Biosimilars Market Status and Prospect (2014-2026)
1.4.7.5 Thailand Biosimilars Market Status and Prospect (2014-2026)
1.4.7.6 Vietnam Biosimilars Market Status and Prospect (2014-2026)
1.4.8 Central and South America Biosimilars Market Status and Prospect (2014-2026)
1.4.8.1 Brazil Biosimilars Market Status and Prospect (2014-2026)
1.4.8.2 Mexico Biosimilars Market Status and Prospect (2014-2026)
1.4.8.3 Colombia Biosimilars Market Status and Prospect (2014-2026)
1.4.9 Middle East and Africa Biosimilars Market Status and Prospect (2014-2026)
1.4.9.1 Saudi Arabia Biosimilars Market Status and Prospect (2014-2026)
1.4.9.2 United Arab Emirates Biosimilars Market Status and Prospect (2014-2026)
1.4.9.3 Turkey Biosimilars Market Status and Prospect (2014-2026)
1.4.9.4 Egypt Biosimilars Market Status and Prospect (2014-2026)
1.4.9.5 South Africa Biosimilars Market Status and Prospect (2014-2026)
1.4.9.6 Nigeria Biosimilars Market Status and Prospect (2014-2026)
1.5 Global Market Size (Value) of Biosimilars (2014-2026)
1.5.1 Global Biosimilars Revenue Status and Outlook (2014-2026)
1.5.2 Global Biosimilars Production Status and Outlook (2014-2026)
2 GLOBAL BIOSIMILARS MARKET LANDSCAPE BY PLAYER
2.1 Global Biosimilars Production and Share by Player (2014-2019)
2.2 Global Biosimilars Revenue and Market Share by Player (2014-2019)
2.3 Global Biosimilars Average Price by Player (2014-2019)
2.4 Biosimilars Manufacturing Base Distribution, Sales Area and Product Type by Player
2.5 Biosimilars Market Competitive Situation and Trends
2.5.1 Biosimilars Market Concentration Rate
2.5.2 Biosimilars Market Share of Top 3 and Top 6 Players
2.5.3 Mergers & Acquisitions, Expansion
3 PLAYERS PROFILES
3.1 Dr. Reddy’s Laboratories Ltd.
3.1.1 Dr. Reddy’s Laboratories Ltd. Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Biosimilars Product Profiles, Application and Specification
3.1.3 Dr. Reddy’s Laboratories Ltd. Biosimilars Market Performance (2014-2019)
3.1.4 Dr. Reddy’s Laboratories Ltd. Business Overview
3.2 Samsung Bioepis
3.2.1 Samsung Bioepis Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Biosimilars Product Profiles, Application and Specification
3.2.3 Samsung Bioepis Biosimilars Market Performance (2014-2019)
3.2.4 Samsung Bioepis Business Overview
3.3 Mylan N.V
3.3.1 Mylan N.V Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Biosimilars Product Profiles, Application and Specification
3.3.3 Mylan N.V Biosimilars Market Performance (2014-2019)
3.3.4 Mylan N.V Business Overview
3.4 F. Hoffmann-La Roche AG
3.4.1 F. Hoffmann-La Roche AG Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Biosimilars Product Profiles, Application and Specification
3.4.3 F. Hoffmann-La Roche AG Biosimilars Market Performance (2014-2019)
3.4.4 F. Hoffmann-La Roche AG Business Overview
3.5 Sandoz International GmbH
3.5.1 Sandoz International GmbH Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Biosimilars Product Profiles, Application and Specification
3.5.3 Sandoz International GmbH Biosimilars Market Performance (2014-2019)
3.5.4 Sandoz International GmbH Business Overview
3.6 Teva Pharmaceutical Industries Ltd.
3.6.1 Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Biosimilars Product Profiles, Application and Specification
3.6.3 Teva Pharmaceutical Industries Ltd. Biosimilars Market Performance (2014-2019)
3.6.4 Teva Pharmaceutical Industries Ltd. Business Overview
3.7 Biocon
3.7.1 Biocon Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Biosimilars Product Profiles, Application and Specification
3.7.3 Biocon Biosimilars Market Performance (2014-2019)
3.7.4 Biocon Business Overview
3.8 Pfizer Inc.
3.8.1 Pfizer Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Biosimilars Product Profiles, Application and Specification
3.8.3 Pfizer Inc. Biosimilars Market Performance (2014-2019)
3.8.4 Pfizer Inc. Business Overview
3.9 Amgen Inc
3.9.1 Amgen Inc Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Biosimilars Product Profiles, Application and Specification
3.9.3 Amgen Inc Biosimilars Market Performance (2014-2019)
3.9.4 Amgen Inc Business Overview
4 GLOBAL BIOSIMILARS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 Global Biosimilars Production and Market Share by Type (2014-2019)
4.2 Global Biosimilars Revenue and Market Share by Type (2014-2019)
4.3 Global Biosimilars Price by Type (2014-2019)
4.4 Global Biosimilars Production Growth Rate by Type (2014-2019)
4.4.1 Global Biosimilars Production Growth Rate of Human growth hormone (2014-2019)
4.4.2 Global Biosimilars Production Growth Rate of Erythropoietin (2014-2019)
4.4.3 Global Biosimilars Production Growth Rate of Monoclonal antibodies (2014-2019)
4.4.4 Global Biosimilars Production Growth Rate of Insulin (2014-2019)
4.4.5 Global Biosimilars Production Growth Rate of Interferon (2014-2019)
4.4.6 Global Biosimilars Production Growth Rate of Granulocyte-Colony Stimulating Factor (2014-2019)
4.4.7 Global Biosimilars Production Growth Rate of Others (2014-2019)
5 GLOBAL BIOSIMILARS MARKET ANALYSIS BY APPLICATION
5.1 Global Biosimilars Consumption and Market Share by Application (2014-2019)
5.2 Global Biosimilars Consumption Growth Rate by Application (2014-2019)
5.2.1 Global Biosimilars Consumption Growth Rate of Oncology (2014-2019)
5.2.2 Global Biosimilars Consumption Growth Rate of Blood Disorders (2014-2019)
5.2.3 Global Biosimilars Consumption Growth Rate of Growth Hormonal Deficiency (2014-2019)
5.2.4 Global Biosimilars Consumption Growth Rate of Chronic and Autoimmune Disorders (2014-2019)
5.2.5 Global Biosimilars Consumption Growth Rate of Others (2014-2019)
6 GLOBAL BIOSIMILARS PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGION (2014-2019)
6.1 Global Biosimilars Consumption by Region (2014-2019)
6.2 United States Biosimilars Production, Consumption, Export, Import (2014-2019)
6.3 Europe Biosimilars Production, Consumption, Export, Import (2014-2019)
6.4 China Biosimilars Production, Consumption, Export, Import (2014-2019)
6.5 Japan Biosimilars Production, Consumption, Export, Import (2014-2019)
6.6 India Biosimilars Production, Consumption, Export, Import (2014-2019)
6.7 Southeast Asia Biosimilars Production, Consumption, Export, Import (2014-2019)
6.8 Central and South America Biosimilars Production, Consumption, Export, Import (2014-2019)
6.9 Middle East and Africa Biosimilars Production, Consumption, Export, Import (2014-2019)
7 GLOBAL BIOSIMILARS PRODUCTION, REVENUE (VALUE) BY REGION (2014-2019)
7.1 Global Biosimilars Production and Market Share by Region (2014-2019)
7.2 Global Biosimilars Revenue (Value) and Market Share by Region (2014-2019)
7.3 Global Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
7.4 United States Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
7.5 Europe Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
7.6 China Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
7.7 Japan Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
7.8 India Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
7.9 Southeast Asia Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
7.10 Central and South America Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
7.11 Middle East and Africa Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
8 BIOSIMILARS MANUFACTURING ANALYSIS
8.1 Biosimilars Key Raw Materials Analysis
8.1.1 Key Raw Materials Introduction
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Manufacturing Cost Analysis
8.2.1 Labor Cost Analysis
8.2.2 Manufacturing Cost Structure Analysis
8.3 Manufacturing Process Analysis of Biosimilars
9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Biosimilars Industrial Chain Analysis
9.2 Raw Materials Sources of Biosimilars Major Players in 2018
9.3 Downstream Buyers
10 MARKET DYNAMICS
10.1 Drivers
10.2 Restraints
10.3 Opportunities
10.3.1 Advances in Innovation and Technology for Biosimilars
10.3.2 Increased Demand in Emerging Markets
10.4 Challenges
10.4.1 The Performance of Alternative Product Type is Getting Better and Better
10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices
10.5 Porter’s Five Forces Analysis
10.5.1 Threat of New Entrants
10.5.2 Threat of Substitutes
10.5.3 Bargaining Power of Suppliers
10.5.4 Bargaining Power of Buyers
10.5.5 Intensity of Competitive Rivalry
11 GLOBAL BIOSIMILARS MARKET FORECAST (2019-2026)
11.1 Global Biosimilars Production, Revenue Forecast (2019-2026)
11.1.1 Global Biosimilars Production and Growth Rate Forecast (2019-2026)
11.1.2 Global Biosimilars Revenue and Growth Rate Forecast (2019-2026)
11.1.3 Global Biosimilars Price and Trend Forecast (2019-2026)
11.2 Global Biosimilars Production, Consumption, Export and Import Forecast by Region (2019-2026)
11.2.1 United States Biosimilars Production, Consumption, Export and Import Forecast (2019-2026)
11.2.2 Europe Biosimilars Production, Consumption, Export and Import Forecast (2019-2026)
11.2.3 China Biosimilars Production, Consumption, Export and Import Forecast (2019-2026)
11.2.4 Japan Biosimilars Production, Consumption, Export and Import Forecast (2019-2026)
11.2.5 India Biosimilars Production, Consumption, Export and Import Forecast (2019-2026)
11.2.6 Southeast Asia Biosimilars Production, Consumption, Export and Import Forecast (2019-2026)
11.2.7 Central and South America Biosimilars Production, Consumption, Export and Import Forecast (2019-2026)
11.2.8 Middle East and Africa Biosimilars Production, Consumption, Export and Import Forecast (2019-2026)
11.3 Global Biosimilars Production, Revenue and Price Forecast by Type (2019-2026)
11.4 Global Biosimilars Consumption Forecast by Application (2019-2026)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Data Source
1.1 Product Overview and Scope of Biosimilars
1.2 Biosimilars Segment by Type
1.2.1 Global Biosimilars Production and CAGR (%) Comparison by Type (2014-2026)
1.2.2 The Market Profile of Human growth hormone
1.2.3 The Market Profile of Erythropoietin
1.2.4 The Market Profile of Monoclonal antibodies
1.2.5 The Market Profile of Insulin
1.2.6 The Market Profile of Interferon
1.2.7 The Market Profile of Granulocyte-Colony Stimulating Factor
1.2.8 The Market Profile of Others
1.3 Global Biosimilars Segment by Application
1.3.1 Biosimilars Consumption (Sales) Comparison by Application (2014-2026)
1.3.2 The Market Profile of Oncology
1.3.3 The Market Profile of Blood Disorders
1.3.4 The Market Profile of Growth Hormonal Deficiency
1.3.5 The Market Profile of Chronic and Autoimmune Disorders
1.3.6 The Market Profile of Others
1.4 Global Biosimilars Market by Region (2014-2026)
1.4.1 Global Biosimilars Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)
1.4.2 United States Biosimilars Market Status and Prospect (2014-2026)
1.4.3 Europe Biosimilars Market Status and Prospect (2014-2026)
1.4.3.1 Germany Biosimilars Market Status and Prospect (2014-2026)
1.4.3.2 UK Biosimilars Market Status and Prospect (2014-2026)
1.4.3.3 France Biosimilars Market Status and Prospect (2014-2026)
1.4.3.4 Italy Biosimilars Market Status and Prospect (2014-2026)
1.4.3.5 Spain Biosimilars Market Status and Prospect (2014-2026)
1.4.3.6 Russia Biosimilars Market Status and Prospect (2014-2026)
1.4.3.7 Poland Biosimilars Market Status and Prospect (2014-2026)
1.4.4 China Biosimilars Market Status and Prospect (2014-2026)
1.4.5 Japan Biosimilars Market Status and Prospect (2014-2026)
1.4.6 India Biosimilars Market Status and Prospect (2014-2026)
1.4.7 Southeast Asia Biosimilars Market Status and Prospect (2014-2026)
1.4.7.1 Malaysia Biosimilars Market Status and Prospect (2014-2026)
1.4.7.2 Singapore Biosimilars Market Status and Prospect (2014-2026)
1.4.7.3 Philippines Biosimilars Market Status and Prospect (2014-2026)
1.4.7.4 Indonesia Biosimilars Market Status and Prospect (2014-2026)
1.4.7.5 Thailand Biosimilars Market Status and Prospect (2014-2026)
1.4.7.6 Vietnam Biosimilars Market Status and Prospect (2014-2026)
1.4.8 Central and South America Biosimilars Market Status and Prospect (2014-2026)
1.4.8.1 Brazil Biosimilars Market Status and Prospect (2014-2026)
1.4.8.2 Mexico Biosimilars Market Status and Prospect (2014-2026)
1.4.8.3 Colombia Biosimilars Market Status and Prospect (2014-2026)
1.4.9 Middle East and Africa Biosimilars Market Status and Prospect (2014-2026)
1.4.9.1 Saudi Arabia Biosimilars Market Status and Prospect (2014-2026)
1.4.9.2 United Arab Emirates Biosimilars Market Status and Prospect (2014-2026)
1.4.9.3 Turkey Biosimilars Market Status and Prospect (2014-2026)
1.4.9.4 Egypt Biosimilars Market Status and Prospect (2014-2026)
1.4.9.5 South Africa Biosimilars Market Status and Prospect (2014-2026)
1.4.9.6 Nigeria Biosimilars Market Status and Prospect (2014-2026)
1.5 Global Market Size (Value) of Biosimilars (2014-2026)
1.5.1 Global Biosimilars Revenue Status and Outlook (2014-2026)
1.5.2 Global Biosimilars Production Status and Outlook (2014-2026)
2 GLOBAL BIOSIMILARS MARKET LANDSCAPE BY PLAYER
2.1 Global Biosimilars Production and Share by Player (2014-2019)
2.2 Global Biosimilars Revenue and Market Share by Player (2014-2019)
2.3 Global Biosimilars Average Price by Player (2014-2019)
2.4 Biosimilars Manufacturing Base Distribution, Sales Area and Product Type by Player
2.5 Biosimilars Market Competitive Situation and Trends
2.5.1 Biosimilars Market Concentration Rate
2.5.2 Biosimilars Market Share of Top 3 and Top 6 Players
2.5.3 Mergers & Acquisitions, Expansion
3 PLAYERS PROFILES
3.1 Dr. Reddy’s Laboratories Ltd.
3.1.1 Dr. Reddy’s Laboratories Ltd. Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Biosimilars Product Profiles, Application and Specification
3.1.3 Dr. Reddy’s Laboratories Ltd. Biosimilars Market Performance (2014-2019)
3.1.4 Dr. Reddy’s Laboratories Ltd. Business Overview
3.2 Samsung Bioepis
3.2.1 Samsung Bioepis Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Biosimilars Product Profiles, Application and Specification
3.2.3 Samsung Bioepis Biosimilars Market Performance (2014-2019)
3.2.4 Samsung Bioepis Business Overview
3.3 Mylan N.V
3.3.1 Mylan N.V Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Biosimilars Product Profiles, Application and Specification
3.3.3 Mylan N.V Biosimilars Market Performance (2014-2019)
3.3.4 Mylan N.V Business Overview
3.4 F. Hoffmann-La Roche AG
3.4.1 F. Hoffmann-La Roche AG Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Biosimilars Product Profiles, Application and Specification
3.4.3 F. Hoffmann-La Roche AG Biosimilars Market Performance (2014-2019)
3.4.4 F. Hoffmann-La Roche AG Business Overview
3.5 Sandoz International GmbH
3.5.1 Sandoz International GmbH Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Biosimilars Product Profiles, Application and Specification
3.5.3 Sandoz International GmbH Biosimilars Market Performance (2014-2019)
3.5.4 Sandoz International GmbH Business Overview
3.6 Teva Pharmaceutical Industries Ltd.
3.6.1 Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Biosimilars Product Profiles, Application and Specification
3.6.3 Teva Pharmaceutical Industries Ltd. Biosimilars Market Performance (2014-2019)
3.6.4 Teva Pharmaceutical Industries Ltd. Business Overview
3.7 Biocon
3.7.1 Biocon Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Biosimilars Product Profiles, Application and Specification
3.7.3 Biocon Biosimilars Market Performance (2014-2019)
3.7.4 Biocon Business Overview
3.8 Pfizer Inc.
3.8.1 Pfizer Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Biosimilars Product Profiles, Application and Specification
3.8.3 Pfizer Inc. Biosimilars Market Performance (2014-2019)
3.8.4 Pfizer Inc. Business Overview
3.9 Amgen Inc
3.9.1 Amgen Inc Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Biosimilars Product Profiles, Application and Specification
3.9.3 Amgen Inc Biosimilars Market Performance (2014-2019)
3.9.4 Amgen Inc Business Overview
4 GLOBAL BIOSIMILARS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 Global Biosimilars Production and Market Share by Type (2014-2019)
4.2 Global Biosimilars Revenue and Market Share by Type (2014-2019)
4.3 Global Biosimilars Price by Type (2014-2019)
4.4 Global Biosimilars Production Growth Rate by Type (2014-2019)
4.4.1 Global Biosimilars Production Growth Rate of Human growth hormone (2014-2019)
4.4.2 Global Biosimilars Production Growth Rate of Erythropoietin (2014-2019)
4.4.3 Global Biosimilars Production Growth Rate of Monoclonal antibodies (2014-2019)
4.4.4 Global Biosimilars Production Growth Rate of Insulin (2014-2019)
4.4.5 Global Biosimilars Production Growth Rate of Interferon (2014-2019)
4.4.6 Global Biosimilars Production Growth Rate of Granulocyte-Colony Stimulating Factor (2014-2019)
4.4.7 Global Biosimilars Production Growth Rate of Others (2014-2019)
5 GLOBAL BIOSIMILARS MARKET ANALYSIS BY APPLICATION
5.1 Global Biosimilars Consumption and Market Share by Application (2014-2019)
5.2 Global Biosimilars Consumption Growth Rate by Application (2014-2019)
5.2.1 Global Biosimilars Consumption Growth Rate of Oncology (2014-2019)
5.2.2 Global Biosimilars Consumption Growth Rate of Blood Disorders (2014-2019)
5.2.3 Global Biosimilars Consumption Growth Rate of Growth Hormonal Deficiency (2014-2019)
5.2.4 Global Biosimilars Consumption Growth Rate of Chronic and Autoimmune Disorders (2014-2019)
5.2.5 Global Biosimilars Consumption Growth Rate of Others (2014-2019)
6 GLOBAL BIOSIMILARS PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGION (2014-2019)
6.1 Global Biosimilars Consumption by Region (2014-2019)
6.2 United States Biosimilars Production, Consumption, Export, Import (2014-2019)
6.3 Europe Biosimilars Production, Consumption, Export, Import (2014-2019)
6.4 China Biosimilars Production, Consumption, Export, Import (2014-2019)
6.5 Japan Biosimilars Production, Consumption, Export, Import (2014-2019)
6.6 India Biosimilars Production, Consumption, Export, Import (2014-2019)
6.7 Southeast Asia Biosimilars Production, Consumption, Export, Import (2014-2019)
6.8 Central and South America Biosimilars Production, Consumption, Export, Import (2014-2019)
6.9 Middle East and Africa Biosimilars Production, Consumption, Export, Import (2014-2019)
7 GLOBAL BIOSIMILARS PRODUCTION, REVENUE (VALUE) BY REGION (2014-2019)
7.1 Global Biosimilars Production and Market Share by Region (2014-2019)
7.2 Global Biosimilars Revenue (Value) and Market Share by Region (2014-2019)
7.3 Global Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
7.4 United States Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
7.5 Europe Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
7.6 China Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
7.7 Japan Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
7.8 India Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
7.9 Southeast Asia Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
7.10 Central and South America Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
7.11 Middle East and Africa Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
8 BIOSIMILARS MANUFACTURING ANALYSIS
8.1 Biosimilars Key Raw Materials Analysis
8.1.1 Key Raw Materials Introduction
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Manufacturing Cost Analysis
8.2.1 Labor Cost Analysis
8.2.2 Manufacturing Cost Structure Analysis
8.3 Manufacturing Process Analysis of Biosimilars
9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Biosimilars Industrial Chain Analysis
9.2 Raw Materials Sources of Biosimilars Major Players in 2018
9.3 Downstream Buyers
10 MARKET DYNAMICS
10.1 Drivers
10.2 Restraints
10.3 Opportunities
10.3.1 Advances in Innovation and Technology for Biosimilars
10.3.2 Increased Demand in Emerging Markets
10.4 Challenges
10.4.1 The Performance of Alternative Product Type is Getting Better and Better
10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices
10.5 Porter’s Five Forces Analysis
10.5.1 Threat of New Entrants
10.5.2 Threat of Substitutes
10.5.3 Bargaining Power of Suppliers
10.5.4 Bargaining Power of Buyers
10.5.5 Intensity of Competitive Rivalry
11 GLOBAL BIOSIMILARS MARKET FORECAST (2019-2026)
11.1 Global Biosimilars Production, Revenue Forecast (2019-2026)
11.1.1 Global Biosimilars Production and Growth Rate Forecast (2019-2026)
11.1.2 Global Biosimilars Revenue and Growth Rate Forecast (2019-2026)
11.1.3 Global Biosimilars Price and Trend Forecast (2019-2026)
11.2 Global Biosimilars Production, Consumption, Export and Import Forecast by Region (2019-2026)
11.2.1 United States Biosimilars Production, Consumption, Export and Import Forecast (2019-2026)
11.2.2 Europe Biosimilars Production, Consumption, Export and Import Forecast (2019-2026)
11.2.3 China Biosimilars Production, Consumption, Export and Import Forecast (2019-2026)
11.2.4 Japan Biosimilars Production, Consumption, Export and Import Forecast (2019-2026)
11.2.5 India Biosimilars Production, Consumption, Export and Import Forecast (2019-2026)
11.2.6 Southeast Asia Biosimilars Production, Consumption, Export and Import Forecast (2019-2026)
11.2.7 Central and South America Biosimilars Production, Consumption, Export and Import Forecast (2019-2026)
11.2.8 Middle East and Africa Biosimilars Production, Consumption, Export and Import Forecast (2019-2026)
11.3 Global Biosimilars Production, Revenue and Price Forecast by Type (2019-2026)
11.4 Global Biosimilars Consumption Forecast by Application (2019-2026)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Biosimilars Product Picture
Table Global Biosimilars Production and CAGR (%) Comparison by Type
Table Profile of Human growth hormone
Table Profile of Erythropoietin
Table Profile of Monoclonal antibodies
Table Profile of Insulin
Table Profile of Interferon
Table Profile of Granulocyte-Colony Stimulating Factor
Table Profile of Others
Table Biosimilars Consumption (Sales) Comparison by Application (2014-2026)
Table Profile of Oncology
Table Profile of Blood Disorders
Table Profile of Growth Hormonal Deficiency
Table Profile of Chronic and Autoimmune Disorders
Table Profile of Others
Figure Global Biosimilars Market Size (Value) and CAGR (%) (2014-2026)
Figure United States Biosimilars Revenue and Growth Rate (2014-2026)
Figure Europe Biosimilars Revenue and Growth Rate (2014-2026)
Figure Germany Biosimilars Revenue and Growth Rate (2014-2026)
Figure UK Biosimilars Revenue and Growth Rate (2014-2026)
Figure France Biosimilars Revenue and Growth Rate (2014-2026)
Figure Italy Biosimilars Revenue and Growth Rate (2014-2026)
Figure Spain Biosimilars Revenue and Growth Rate (2014-2026)
Figure Russia Biosimilars Revenue and Growth Rate (2014-2026)
Figure Poland Biosimilars Revenue and Growth Rate (2014-2026)
Figure China Biosimilars Revenue and Growth Rate (2014-2026)
Figure Japan Biosimilars Revenue and Growth Rate (2014-2026)
Figure India Biosimilars Revenue and Growth Rate (2014-2026)
Figure Southeast Asia Biosimilars Revenue and Growth Rate (2014-2026)
Figure Malaysia Biosimilars Revenue and Growth Rate (2014-2026)
Figure Singapore Biosimilars Revenue and Growth Rate (2014-2026)
Figure Philippines Biosimilars Revenue and Growth Rate (2014-2026)
Figure Indonesia Biosimilars Revenue and Growth Rate (2014-2026)
Figure Thailand Biosimilars Revenue and Growth Rate (2014-2026)
Figure Vietnam Biosimilars Revenue and Growth Rate (2014-2026)
Figure Central and South America Biosimilars Revenue and Growth Rate (2014-2026)
Figure Brazil Biosimilars Revenue and Growth Rate (2014-2026)
Figure Mexico Biosimilars Revenue and Growth Rate (2014-2026)
Figure Colombia Biosimilars Revenue and Growth Rate (2014-2026)
Figure Middle East and Africa Biosimilars Revenue and Growth Rate (2014-2026)
Figure Saudi Arabia Biosimilars Revenue and Growth Rate (2014-2026)
Figure United Arab Emirates Biosimilars Revenue and Growth Rate (2014-2026)
Figure Turkey Biosimilars Revenue and Growth Rate (2014-2026)
Figure Egypt Biosimilars Revenue and Growth Rate (2014-2026)
Figure South Africa Biosimilars Revenue and Growth Rate (2014-2026)
Figure Nigeria Biosimilars Revenue and Growth Rate (2014-2026)
Figure Global Biosimilars Production Status and Outlook (2014-2026)
Table Global Biosimilars Production by Player (2014-2019)
Table Global Biosimilars Production Share by Player (2014-2019)
Figure Global Biosimilars Production Share by Player in 2018
Table Biosimilars Revenue by Player (2014-2019)
Table Biosimilars Revenue Market Share by Player (2014-2019)
Table Biosimilars Price by Player (2014-2019)
Table Biosimilars Manufacturing Base Distribution and Sales Area by Player
Table Biosimilars Product Type by Player
Table Mergers & Acquisitions, Expansion Plans
Table Dr. Reddy’s Laboratories Ltd. Profile
Table Dr. Reddy’s Laboratories Ltd. Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
Table Samsung Bioepis Profile
Table Samsung Bioepis Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
Table Mylan N.V Profile
Table Mylan N.V Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
Table F. Hoffmann-La Roche AG Profile
Table F. Hoffmann-La Roche AG Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
Table Sandoz International GmbH Profile
Table Sandoz International GmbH Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
Table Teva Pharmaceutical Industries Ltd. Profile
Table Teva Pharmaceutical Industries Ltd. Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
Table Biocon Profile
Table Biocon Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
Table Pfizer Inc. Profile
Table Pfizer Inc. Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
Table Amgen Inc Profile
Table Amgen Inc Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
Table Global Biosimilars Production by Type (2014-2019)
Table Global Biosimilars Production Market Share by Type (2014-2019)
Figure Global Biosimilars Production Market Share by Type in 2018
Table Global Biosimilars Revenue by Type (2014-2019)
Table Global Biosimilars Revenue Market Share by Type (2014-2019)
Figure Global Biosimilars Revenue Market Share by Type in 2018
Table Biosimilars Price by Type (2014-2019)
Figure Global Biosimilars Production Growth Rate of Human growth hormone (2014-2019)
Figure Global Biosimilars Production Growth Rate of Erythropoietin (2014-2019)
Figure Global Biosimilars Production Growth Rate of Monoclonal antibodies (2014-2019)
Figure Global Biosimilars Production Growth Rate of Insulin (2014-2019)
Figure Global Biosimilars Production Growth Rate of Interferon (2014-2019)
Figure Global Biosimilars Production Growth Rate of Granulocyte-Colony Stimulating Factor (2014-2019)
Figure Global Biosimilars Production Growth Rate of Others (2014-2019)
Table Global Biosimilars Consumption by Application (2014-2019)
Table Global Biosimilars Consumption Market Share by Application (2014-2019)
Table Global Biosimilars Consumption of Oncology (2014-2019)
Table Global Biosimilars Consumption of Blood Disorders (2014-2019)
Table Global Biosimilars Consumption of Growth Hormonal Deficiency (2014-2019)
Table Global Biosimilars Consumption of Chronic and Autoimmune Disorders (2014-2019)
Table Global Biosimilars Consumption of Others (2014-2019)
Table Global Biosimilars Consumption by Region (2014-2019)
Table Global Biosimilars Consumption Market Share by Region (2014-2019)
Table United States Biosimilars Production, Consumption, Export, Import (2014-2019)
Table Europe Biosimilars Production, Consumption, Export, Import (2014-2019)
Table China Biosimilars Production, Consumption, Export, Import (2014-2019)
Table Japan Biosimilars Production, Consumption, Export, Import (2014-2019)
Table India Biosimilars Production, Consumption, Export, Import (2014-2019)
Table Southeast Asia Biosimilars Production, Consumption, Export, Import (2014-2019)
Table Central and South America Biosimilars Production, Consumption, Export, Import (2014-2019)
Table Middle East and Africa Biosimilars Production, Consumption, Export, Import (2014-2019)
Table Global Biosimilars Production by Region (2014-2019)
Table Global Biosimilars Production Market Share by Region (2014-2019)
Figure Global Biosimilars Production Market Share by Region (2014-2019)
Figure Global Biosimilars Production Market Share by Region in 2018
Table Global Biosimilars Revenue by Region (2014-2019)
Table Global Biosimilars Revenue Market Share by Region (2014-2019)
Figure Global Biosimilars Revenue Market Share by Region (2014-2019)
Figure Global Biosimilars Revenue Market Share by Region in 2018
Table Global Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
Table United States Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
Table Europe Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
Table China Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
Table Japan Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
Table India Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
Table Southeast Asia Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
Table Central and South America Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
Table Middle East and Africa Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
Table Key Raw Materials Introduction of Biosimilars
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Market Concentration Rate of Raw Materials
Figure Manufacturing Cost Structure Analysis
Figure Manufacturing Process Analysis of Biosimilars
Figure Biosimilars Industrial Chain Analysis
Table Raw Materials Sources of Biosimilars Major Players in 2018
Table Downstream Buyers
Figure Global Biosimilars Production and Growth Rate Forecast (2019-2026)
Figure Global Biosimilars Revenue and Growth Rate Forecast (2019-2026)
Figure Global Biosimilars Price and Trend Forecast (2019-2026)
Table United States Biosimilars Production, Consumption, Export and Import Forecast (2019-2026)
Table Europe Biosimilars Production, Consumption, Export and Import Forecast (2019-2026)
Table China Biosimilars Production, Consumption, Export and Import Forecast (2019-2026)
Table Japan Biosimilars Production, Consumption, Export and Import Forecast (2019-2026)
Table India Biosimilars Production, Consumption, Export and Import Forecast (2019-2026)
Table Southeast Asia Biosimilars Production, Consumption, Export and Import Forecast (2019-2026)
Table Southeast Asia Biosimilars Production, Consumption, Export and Import Forecast (2019-2026)
Table Middle East and Africa Biosimilars Production, Consumption, Export and Import Forecast (2019-2026)
Table Global Biosimilars Market Production Forecast, by Type
Table Global Biosimilars Production Volume Market Share Forecast, by Type
Table Global Biosimilars Market Revenue Forecast, by Type
Table Global Biosimilars Revenue Market Share Forecast, by Type
Table Global Biosimilars Price Forecast, by Type
Table Global Biosimilars Market Production Forecast, by Application
Table Global Biosimilars Production Volume Market Share Forecast, by Application
Table Global Biosimilars Market Revenue Forecast, by Application
Table Global Biosimilars Revenue Market Share Forecast, by Application
Table Global Biosimilars Price Forecast, by Application
Figure Biosimilars Product Picture
Table Global Biosimilars Production and CAGR (%) Comparison by Type
Table Profile of Human growth hormone
Table Profile of Erythropoietin
Table Profile of Monoclonal antibodies
Table Profile of Insulin
Table Profile of Interferon
Table Profile of Granulocyte-Colony Stimulating Factor
Table Profile of Others
Table Biosimilars Consumption (Sales) Comparison by Application (2014-2026)
Table Profile of Oncology
Table Profile of Blood Disorders
Table Profile of Growth Hormonal Deficiency
Table Profile of Chronic and Autoimmune Disorders
Table Profile of Others
Figure Global Biosimilars Market Size (Value) and CAGR (%) (2014-2026)
Figure United States Biosimilars Revenue and Growth Rate (2014-2026)
Figure Europe Biosimilars Revenue and Growth Rate (2014-2026)
Figure Germany Biosimilars Revenue and Growth Rate (2014-2026)
Figure UK Biosimilars Revenue and Growth Rate (2014-2026)
Figure France Biosimilars Revenue and Growth Rate (2014-2026)
Figure Italy Biosimilars Revenue and Growth Rate (2014-2026)
Figure Spain Biosimilars Revenue and Growth Rate (2014-2026)
Figure Russia Biosimilars Revenue and Growth Rate (2014-2026)
Figure Poland Biosimilars Revenue and Growth Rate (2014-2026)
Figure China Biosimilars Revenue and Growth Rate (2014-2026)
Figure Japan Biosimilars Revenue and Growth Rate (2014-2026)
Figure India Biosimilars Revenue and Growth Rate (2014-2026)
Figure Southeast Asia Biosimilars Revenue and Growth Rate (2014-2026)
Figure Malaysia Biosimilars Revenue and Growth Rate (2014-2026)
Figure Singapore Biosimilars Revenue and Growth Rate (2014-2026)
Figure Philippines Biosimilars Revenue and Growth Rate (2014-2026)
Figure Indonesia Biosimilars Revenue and Growth Rate (2014-2026)
Figure Thailand Biosimilars Revenue and Growth Rate (2014-2026)
Figure Vietnam Biosimilars Revenue and Growth Rate (2014-2026)
Figure Central and South America Biosimilars Revenue and Growth Rate (2014-2026)
Figure Brazil Biosimilars Revenue and Growth Rate (2014-2026)
Figure Mexico Biosimilars Revenue and Growth Rate (2014-2026)
Figure Colombia Biosimilars Revenue and Growth Rate (2014-2026)
Figure Middle East and Africa Biosimilars Revenue and Growth Rate (2014-2026)
Figure Saudi Arabia Biosimilars Revenue and Growth Rate (2014-2026)
Figure United Arab Emirates Biosimilars Revenue and Growth Rate (2014-2026)
Figure Turkey Biosimilars Revenue and Growth Rate (2014-2026)
Figure Egypt Biosimilars Revenue and Growth Rate (2014-2026)
Figure South Africa Biosimilars Revenue and Growth Rate (2014-2026)
Figure Nigeria Biosimilars Revenue and Growth Rate (2014-2026)
Figure Global Biosimilars Production Status and Outlook (2014-2026)
Table Global Biosimilars Production by Player (2014-2019)
Table Global Biosimilars Production Share by Player (2014-2019)
Figure Global Biosimilars Production Share by Player in 2018
Table Biosimilars Revenue by Player (2014-2019)
Table Biosimilars Revenue Market Share by Player (2014-2019)
Table Biosimilars Price by Player (2014-2019)
Table Biosimilars Manufacturing Base Distribution and Sales Area by Player
Table Biosimilars Product Type by Player
Table Mergers & Acquisitions, Expansion Plans
Table Dr. Reddy’s Laboratories Ltd. Profile
Table Dr. Reddy’s Laboratories Ltd. Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
Table Samsung Bioepis Profile
Table Samsung Bioepis Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
Table Mylan N.V Profile
Table Mylan N.V Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
Table F. Hoffmann-La Roche AG Profile
Table F. Hoffmann-La Roche AG Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
Table Sandoz International GmbH Profile
Table Sandoz International GmbH Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
Table Teva Pharmaceutical Industries Ltd. Profile
Table Teva Pharmaceutical Industries Ltd. Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
Table Biocon Profile
Table Biocon Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
Table Pfizer Inc. Profile
Table Pfizer Inc. Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
Table Amgen Inc Profile
Table Amgen Inc Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
Table Global Biosimilars Production by Type (2014-2019)
Table Global Biosimilars Production Market Share by Type (2014-2019)
Figure Global Biosimilars Production Market Share by Type in 2018
Table Global Biosimilars Revenue by Type (2014-2019)
Table Global Biosimilars Revenue Market Share by Type (2014-2019)
Figure Global Biosimilars Revenue Market Share by Type in 2018
Table Biosimilars Price by Type (2014-2019)
Figure Global Biosimilars Production Growth Rate of Human growth hormone (2014-2019)
Figure Global Biosimilars Production Growth Rate of Erythropoietin (2014-2019)
Figure Global Biosimilars Production Growth Rate of Monoclonal antibodies (2014-2019)
Figure Global Biosimilars Production Growth Rate of Insulin (2014-2019)
Figure Global Biosimilars Production Growth Rate of Interferon (2014-2019)
Figure Global Biosimilars Production Growth Rate of Granulocyte-Colony Stimulating Factor (2014-2019)
Figure Global Biosimilars Production Growth Rate of Others (2014-2019)
Table Global Biosimilars Consumption by Application (2014-2019)
Table Global Biosimilars Consumption Market Share by Application (2014-2019)
Table Global Biosimilars Consumption of Oncology (2014-2019)
Table Global Biosimilars Consumption of Blood Disorders (2014-2019)
Table Global Biosimilars Consumption of Growth Hormonal Deficiency (2014-2019)
Table Global Biosimilars Consumption of Chronic and Autoimmune Disorders (2014-2019)
Table Global Biosimilars Consumption of Others (2014-2019)
Table Global Biosimilars Consumption by Region (2014-2019)
Table Global Biosimilars Consumption Market Share by Region (2014-2019)
Table United States Biosimilars Production, Consumption, Export, Import (2014-2019)
Table Europe Biosimilars Production, Consumption, Export, Import (2014-2019)
Table China Biosimilars Production, Consumption, Export, Import (2014-2019)
Table Japan Biosimilars Production, Consumption, Export, Import (2014-2019)
Table India Biosimilars Production, Consumption, Export, Import (2014-2019)
Table Southeast Asia Biosimilars Production, Consumption, Export, Import (2014-2019)
Table Central and South America Biosimilars Production, Consumption, Export, Import (2014-2019)
Table Middle East and Africa Biosimilars Production, Consumption, Export, Import (2014-2019)
Table Global Biosimilars Production by Region (2014-2019)
Table Global Biosimilars Production Market Share by Region (2014-2019)
Figure Global Biosimilars Production Market Share by Region (2014-2019)
Figure Global Biosimilars Production Market Share by Region in 2018
Table Global Biosimilars Revenue by Region (2014-2019)
Table Global Biosimilars Revenue Market Share by Region (2014-2019)
Figure Global Biosimilars Revenue Market Share by Region (2014-2019)
Figure Global Biosimilars Revenue Market Share by Region in 2018
Table Global Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
Table United States Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
Table Europe Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
Table China Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
Table Japan Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
Table India Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
Table Southeast Asia Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
Table Central and South America Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
Table Middle East and Africa Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
Table Key Raw Materials Introduction of Biosimilars
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Market Concentration Rate of Raw Materials
Figure Manufacturing Cost Structure Analysis
Figure Manufacturing Process Analysis of Biosimilars
Figure Biosimilars Industrial Chain Analysis
Table Raw Materials Sources of Biosimilars Major Players in 2018
Table Downstream Buyers
Figure Global Biosimilars Production and Growth Rate Forecast (2019-2026)
Figure Global Biosimilars Revenue and Growth Rate Forecast (2019-2026)
Figure Global Biosimilars Price and Trend Forecast (2019-2026)
Table United States Biosimilars Production, Consumption, Export and Import Forecast (2019-2026)
Table Europe Biosimilars Production, Consumption, Export and Import Forecast (2019-2026)
Table China Biosimilars Production, Consumption, Export and Import Forecast (2019-2026)
Table Japan Biosimilars Production, Consumption, Export and Import Forecast (2019-2026)
Table India Biosimilars Production, Consumption, Export and Import Forecast (2019-2026)
Table Southeast Asia Biosimilars Production, Consumption, Export and Import Forecast (2019-2026)
Table Southeast Asia Biosimilars Production, Consumption, Export and Import Forecast (2019-2026)
Table Middle East and Africa Biosimilars Production, Consumption, Export and Import Forecast (2019-2026)
Table Global Biosimilars Market Production Forecast, by Type
Table Global Biosimilars Production Volume Market Share Forecast, by Type
Table Global Biosimilars Market Revenue Forecast, by Type
Table Global Biosimilars Revenue Market Share Forecast, by Type
Table Global Biosimilars Price Forecast, by Type
Table Global Biosimilars Market Production Forecast, by Application
Table Global Biosimilars Production Volume Market Share Forecast, by Application
Table Global Biosimilars Market Revenue Forecast, by Application
Table Global Biosimilars Revenue Market Share Forecast, by Application
Table Global Biosimilars Price Forecast, by Application
